Filter
438
Text search:
drug
stability
testing
Featured
Recommendations
37
New Publications
109
Language
Document type
No document type
268
Guidelines
63
Studies & Reports
56
Manuals
27
Strategic & Response Plan
13
Situation Updates
4
Training Material
3
Fact sheets
3
Infographics
1
Countries / Regions
India
21
Uganda
14
Kenya
14
Liberia
13
South Africa
12
Global
11
Nigeria
10
Zambia
10
Tanzania
10
Ethiopia
9
Sierra Leone
8
Malawi
8
Western and Central Europe
8
Rwanda
7
Zimbabwe
6
Bangladesh
6
Namibia
6
Asia
6
Ghana
5
Cambodia
5
Ukraine
5
Nepal
4
Botswana
4
Eastern Europe
4
South Sudan
3
Mozambique
3
Middle East and North Africa
3
Guinea
2
Senegal
2
Congo, Democratic Republic of
2
USA
2
Lesotho
2
West and Central Africa
2
South–East Asia Region
2
Latin America and the Carribbean
2
Eastern Europe and Central Asia
2
Russia
2
Burkina Faso
1
Philippines
1
Iraq
1
Syria
1
China
1
Indonesia
1
Malaysia
1
Sudan
1
Colombia
1
Myanmar / Burma
1
Yemen
1
East and Southern Africa
1
Western Pacific Region
1
Africa
1
Albania
1
Moldova
1
Australia
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
175
Clinical Guidelines
41
Pharmacy & Technologies
19
Public Health
13
Key Resources
13
Women & Child Health
12
Capacity Building
8
Toolboxes
HIV
55
Mental Health
34
TB
32
Pharmacy
27
COVID-19
23
NTDs
15
Malaria
15
AMR
14
Ebola & Marburg
10
Rapid Response
9
Caregiver
6
Health Financing Toolbox
5
Conflict
4
Planetary Health
4
NCDs
4
2.0 Rapid Response
4
Natural Hazards
3
Global Health Education
3
Refugee
2
Specific Hazards
2
Disability
1
Zika
1
Social Ethics
1
Clinical Pharmacology: Advances and Applications, 2025:17 29–47
Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to
...
F1000Research 2019, 8:323 Last updated: 17 MAY 2019
African Health Sciences 2013; 13(2): 219 - 232 http://dx.doi.org/10.4314/ahs.v13i2.4
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
Psychatry & Pediatrics
Chapter I.3
This Training module on malaria elimination has been developed by WHO to support health professionals in planning, managing, monitoring and evaluating malaria elimination programmes
Position Statement
Diabetes Care2018;42(Suppl. 1):S1–S194.
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact
...
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex
...
Fourth Edition
The intended purpose of this compendium is to provide program managers, organizations, and policy makers with a menu of indicators to better “know their HIV epidemic/know their response” from a gender perspective. The indicators in the compendium are all either part of existing indicators used i
...